These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chenodeoxycholic acid therapy in erythrohepatic protoporphyria. Van Hattum J; Baart de la Faille H; Van den Berg JW; Edixhoven-Bosdijk A; Wilson JH J Hepatol; 1986; 3(3):407-12. PubMed ID: 3559148 [TBL] [Abstract][Full Text] [Related]
4. Iron therapy for hepatic dysfunction in erythropoietic protoporphyria. Gordeuk VR; Brittenham GM; Hawkins CW; Mukhtar H; Bickers DR Ann Intern Med; 1986 Jul; 105(1):27-31. PubMed ID: 3717807 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and therapy of liver disease in protoporphyria. Bloomer JR Yale J Biol Med; 1979; 52(1):39-48. PubMed ID: 452621 [TBL] [Abstract][Full Text] [Related]
6. [Porphyrin metabolism disorders in man--erythropoietic and hepatic porphyrias]. Goerz G; Krieg T; Lissner R; Vizethum W Z Hautkr; 1979 Feb; 54(4):153-68. PubMed ID: 425604 [No Abstract] [Full Text] [Related]
12. [Acute hepatic porphyrias. 1. The breath test with C-14-aminopyrine, serum bile acid levels and routine tests in the evaluation of liver function]. Ostrowski J; Kostrzewska E; Medrzejewski W; Gregor A Pol Arch Med Wewn; 1984 Feb; 71(2):79-86. PubMed ID: 6739316 [No Abstract] [Full Text] [Related]